First Quadrant’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,024
Closed -$1.54M 518
2021
Q4
$1.54M Hold
7,024
0.17% 123
2021
Q3
$1.27M Buy
7,024
+2,400
+52% +$435K 0.15% 133
2021
Q2
$932K Sell
4,624
-3,671
-44% -$740K 0.11% 175
2021
Q1
$1.78M Sell
8,295
-5,274
-39% -$1.13M 0.19% 113
2020
Q4
$3.21M Sell
13,569
-1,465
-10% -$346K 0.32% 51
2020
Q3
$4.09M Sell
15,034
-2,003
-12% -$545K 0.52% 32
2020
Q2
$4.95M Sell
17,037
-5,952
-26% -$1.73M 0.66% 25
2020
Q1
$5.47M Buy
22,989
+11,368
+98% +$2.7M 0.8% 20
2019
Q4
$2.54M Sell
11,621
-6,198
-35% -$1.36M 0.21% 102
2019
Q3
$3.02M Sell
17,819
-845
-5% -$143K 0.28% 90
2019
Q2
$3.42M Buy
18,664
+12,360
+196% +$2.27M 0.24% 104
2019
Q1
$1.16M Sell
6,304
-878
-12% -$162K 0.09% 239
2018
Q4
$1.19M Sell
7,182
-127,235
-95% -$21.1M 0.1% 214
2018
Q3
$25.9M Sell
134,417
-58,510
-30% -$11.3M 0.58% 30
2018
Q2
$32.8M Buy
192,927
+1,298
+0.7% +$221K 0.61% 30
2018
Q1
$31.2M Buy
191,629
+55,646
+41% +$9.07M 0.6% 23
2017
Q4
$20.4M Buy
135,983
+6,168
+5% +$924K 0.38% 88
2017
Q3
$19.7M Buy
129,815
+127,856
+6,527% +$19.4M 0.38% 85
2017
Q2
$252K Buy
1,959
+1,459
+292% +$188K 0.01% 649
2017
Q1
$55K Hold
500
﹤0.01% 745
2016
Q4
$37K Hold
500
﹤0.01% 782
2016
Q3
$44K Hold
500
﹤0.01% 796
2016
Q2
$43K Hold
500
﹤0.01% 720
2016
Q1
$40K Buy
+500
New +$40K ﹤0.01% 701
2015
Q4
Sell
-400
Closed -$42K 844
2015
Q3
$42K Buy
400
+200
+100% +$21K ﹤0.01% 692
2015
Q2
$25K Buy
+200
New +$25K ﹤0.01% 729